Research into the potential of Natural Killer (NK) cells in treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis is gaining traction, though it’s still in its nascent stages. NK cells, a component of the innate immune system, are known for targeting infected or abnormal cells and influencing inflammatory responses. Scientists are exploring how these cells might interact with the chronic inflammation and protein accumulation characteristic of diseases such as Alzheimer’s and Parkinson’s. However, it’s important to note that current clinical evidence does not yet support NK cell therapy as a treatment for these conditions.
In 2025, a Phase I clinical trial explored the safety of expanded NK cells in Alzheimer’s patients. Eleven participants, with ten included in the final analysis, received intravenous infusions of autologous, non-genetically modified expanded NK cells every three weeks. Researchers focused on safety and monitored cognitive functions and biomarkers related to neuroinflammation, neurodegeneration, amyloid, and tau proteins. Although no adverse effects from the NK cell product itself were reported, and some changes in cognitive measures and biomarkers were observed, this small-scale study was not intended to validate NK cell therapy as an effective treatment for Alzheimer’s. Comprehensive randomized controlled trials with extended follow-up periods are necessary to determine any substantial clinical benefits.
Interest in NK cells extends to Parkinson’s disease, bolstered by preclinical findings. A 2020 study highlighted the ability of NK cells to interact with and degrade alpha-synuclein aggregates in laboratory and animal models. The research also noted increased pathology and neuroinflammation when NK cells were depleted in a mouse model, suggesting a regulatory role in immune activity associated with Parkinson’s. Despite these promising insights, the evidence remains largely preclinical, and NK cell therapy for Parkinson’s has yet to be proven effective in humans.
The complexity of NK cells’ roles in neurological diseases presents challenges. Different populations of NK cells can serve distinct functions, and their impact may vary based on disease type, stage, and the surrounding tissue environment. Simply increasing NK cell numbers may not yield beneficial outcomes. Researchers are examining which NK cell populations, activation states, dosages, and treatment schedules might be effective. Critical questions remain, including how NK cells affect the central nervous system, their duration of activity, patient suitability, and potential to alter disease progression. Long-term clinical outcomes will be crucial for assessing the therapeutic value of NK cell therapy.
While NK cell therapy remains an investigational area within cellular medicine, early studies are generating interest. However, more extensive clinical research is required to evaluate its efficacy and safety over the long term. The R3 Life Wellness Center advises individuals considering such therapies to consult healthcare professionals and review scientific evidence, safety data, and regulatory status. This article is intended for educational purposes only and does not offer medical advice or treatment options, as NK cell therapy for neurodegenerative diseases is still under investigation and not an established treatment.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.